As of Oct 20
| +0.58 / +0.40%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 151.00, with a high estimate of 160.00 and a low estimate of 104.00. The median estimate represents a +4.91% increase from the last price of 143.93.
The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.